
Vgenomics is a biotech company based in Delhi, India, focused on revolutionizing personalized medicine for rare inborn diseases through advanced genomics and AI. They develop innovative diagnostics and therapeutic solutions, including comprehensive blood tests capable of diagnosing over 100 rare diseases for newborn and parental screening. Their services include Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and RNA Sequencing (RNA-Seq), tailored for pediatric and neonatal care. Vgenomics aims to reduce diagnosis time and accelerate treatment development from 10-15 years to 3-5 years. The company collaborates with leading Indian medical and research institutions and leverages a team with extensive research publications and patents, positioning itself as a leader in rare disease diagnostics and therapeutics in India and globally.

Vgenomics is a biotech company based in Delhi, India, focused on revolutionizing personalized medicine for rare inborn diseases through advanced genomics and AI. They develop innovative diagnostics and therapeutic solutions, including comprehensive blood tests capable of diagnosing over 100 rare diseases for newborn and parental screening. Their services include Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and RNA Sequencing (RNA-Seq), tailored for pediatric and neonatal care. Vgenomics aims to reduce diagnosis time and accelerate treatment development from 10-15 years to 3-5 years. The company collaborates with leading Indian medical and research institutions and leverages a team with extensive research publications and patents, positioning itself as a leader in rare disease diagnostics and therapeutics in India and globally.